Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1559)	5/17/1999 7:13:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

Bio '99 to showcase technology, treatment By August Cole, CBS MarketWatch Last Update: 3:56 PM ET May 16, 1999 Biotech stocks SEATTLE (CBS.MW) -- The world's largest biotechnology trade show kicks off Sunday, giving industry giants and start-ups a chance to discuss and showcase their products and technological developments. Glaxo Wellcome (GLX: news, msgs), Eli Lilly (LLY: news, msgs), Johnson & Johnson (JNJ: news, msgs) and Bristol-Myers Squibb (BMY: news, msgs) and Immunex (IMNX: news, msgs) are among the companies in attendance. The Seattle Times reported the conference is expected to draw over 5,000 executives from the industry. There are currently more than 120 biotech companies in Washington state, the Seattle Times said. Among them, Bothell, Wash.-based ICOS (ICOS: news, msgs) will showcase its developing impotence drug. The treatment is seen as a potential challenger to Pfizer's Viagra. The Seattle Times quoted Icos' CEO, president and chairman George Rathmann as saying, ""I've been getting calls for two months now from people asking, 'Can I see you at Bio '99,?' " August Cole is an assistant news editor for CBS MarketWatch.